Acute doxorubicin cardiotoxicity: functional, metabolic, and morphologic alterations in the isolated, perfused rat heart
- PMID: 2429080
Acute doxorubicin cardiotoxicity: functional, metabolic, and morphologic alterations in the isolated, perfused rat heart
Abstract
The acute effects of doxorubicin on coronary perfusion and left ventricular pressures and intracellular phosphate metabolite levels, the latter obtained by 31P nuclear magnetic resonance, were measured simultaneously in isolated, isovolumic rat hearts (Langendorf preparation) perfused at constant flow. Nineteen experimental hearts were perfused for 70 min with oxygenated HEPES-buffered solution containing 6 mg/L doxorubicin. These were compared with 18 control hearts (C), perfused under identical conditions but without doxorubicin, by repeated measures analysis of variance. In the experimental group, coronary perfusion pressure steadily increased to 226.3 +/- 13.8% (mean +/- SEM) of initial levels (p less than 0.0001 vs. C). Because flow was constant, the increase in coronary perfusion pressure in experimental hearts indicates a greater than twofold increase in coronary resistance. Intracellular phosphocreatine and ATP decreased to 80.3 +/- 3.9% (p less than 0.005 vs. C) and 82.1 +/- 6.4% (p less than 0.05 vs. C), whereas inorganic phosphate increased to 149.7 +/- 19.1% (p less than 0.05 vs. C) of initial levels, respectively. Accompanying these changes, diastolic pressure steadily increased to 521.7 +/- 91.4% of initial levels (p less than 0.0001 vs. C). Developed pressure initially increased to 107.1 +/- 4.5% at 30 min, and thereafter decreased to 76.2 +/- 6.3% at 70 min (p less than 0.05 vs. C). Typical structural alterations in myocyte nuclei were noted. Cellular calcium was not increased in doxorubicin-exposed hearts. Thus, acute doxorubicin cardiotoxicity is characterized by an increase in coronary resistance and is closely correlated with alterations in ventricular function and a decrease in intracellular high-energy phosphate content.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Use of the isolated perfused heart for evaluation of cardiac toxicity.Toxicol Pathol. 1990;18(4 Pt 1):497-510. Toxicol Pathol. 1990. PMID: 2091229 Review.
-
Stabilization of mitochondrial membrane potential prevents doxorubicin-induced cardiotoxicity in isolated rat heart.Toxicol Appl Pharmacol. 2010 May 1;244(3):300-7. doi: 10.1016/j.taap.2010.01.006. Epub 2010 Jan 20. Toxicol Appl Pharmacol. 2010. PMID: 20096298
-
The effects of Ca++ on the preservation of myocardial energy and function with University of Wisconsin solution. A 31P nuclear magnetic resonance study of isolated blood perfused Langendorff pig hearts.J Heart Lung Transplant. 1993 Jan-Feb;12(1 Pt 1):81-8. J Heart Lung Transplant. 1993. PMID: 8443206
-
Endothelin-1 increases susceptibility of isolated rat hearts to ischemia/reperfusion injury by reducing coronary flow.J Mol Cell Cardiol. 1998 Dec;30(12):2657-68. doi: 10.1006/jmcc.1998.0822. J Mol Cell Cardiol. 1998. PMID: 9990537
-
The isolated heart preparation.Br J Anaesth. 1988;60(8 Suppl 1):28S-34S. doi: 10.1093/bja/60.suppl_1.28s. Br J Anaesth. 1988. PMID: 3284562 Review.
Cited by
-
Evaluation of anthracycline cardiotoxicity with the model of isolated, perfused rat heart: comparison of new analogues versus doxorubicin.Cancer Chemother Pharmacol. 1995;35(3):257-61. doi: 10.1007/BF00686558. Cancer Chemother Pharmacol. 1995. PMID: 7805186
-
Doxorubicin-Induced Cardiomyopathy in Children.Compr Physiol. 2019 Jun 12;9(3):905-931. doi: 10.1002/cphy.c180017. Compr Physiol. 2019. PMID: 31187890 Free PMC article. Review.
-
Development of the model of rat isolated perfused heart for the evaluation of anthracycline cardiotoxicity and its circumvention.Br J Pharmacol. 1996 Apr;117(7):1593-9. doi: 10.1111/j.1476-5381.1996.tb15326.x. Br J Pharmacol. 1996. PMID: 8730759 Free PMC article.
-
Influence of P-glycoprotein modulators on cardiac uptake, metabolism, and effects of idarubicin.Pharm Res. 2001 Nov;18(11):1535-41. doi: 10.1023/a:1013022212738. Pharm Res. 2001. PMID: 11758760
-
Diastolic or systolic left and right ventricular impairment at moderate doses of anthracycline? A 1-year follow-up study of women.Eur J Nucl Med. 1996 May;23(5):511-6. doi: 10.1007/BF00833384. Eur J Nucl Med. 1996. PMID: 8698054
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources